Page last updated: 2024-10-27

flumazenil and Prader-Willi Syndrome

flumazenil has been researched along with Prader-Willi Syndrome in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Prader-Willi Syndrome: An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lucignani, G1
Panzacchi, A1
Bosio, L1
Moresco, RM1
Ravasi, L1
Coppa, I1
Chiumello, G1
Frey, K1
Koeppe, R1
Fazio, F1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Cross-Species Multi-Modal Neuroimaging to Investigate GABA Physiology in Fragile X Syndrome[NCT04308954]Phase 117 participants (Actual)Interventional2016-11-01Terminated (stopped due to Difficulty with patient recruitment due to COVID-19 pandemic)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for flumazenil and Prader-Willi Syndrome

ArticleYear
GABA A receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil.
    NeuroImage, 2004, Volume: 22, Issue:1

    Topics: Adult; Brain; Carbon Radioisotopes; Chromosome Deletion; Female; Flumazenil; GABA Modulators; Humans

2004